Imunon, Inc. Stock-Based Compensation
Imunon, Inc. (IMNN) reported Stock-Based Compensation of $641.87 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-11
- Imunon, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $93.28K, a 23.94% decline year-over-year.
- Imunon, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $548.59K, a 168.22% increase year-over-year.
- Imunon, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $11.48K, a 89.85% decline year-over-year.
- Imunon, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was -$211.28K, a 190.97% decline year-over-year.
- Imunon, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $127.37K, a 73.31% decline from fiscal 2024.
- Imunon, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $477.26K, a 37.12% decline from fiscal 2023.
- Imunon, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $759.01K, a 71.60% decline from fiscal 2022.
- Imunon, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $2.67M, a 28.90% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $93.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $641.87K 10-Q · filed 2026-08-11 | $653.35K derived: sum of 3 quarters · filed 2026-08-11 | $442.07K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2026-03-31 | $548.59K 10-Q · filed 2026-05-12 | $560.07K derived: sum of 2 quarters · filed 2026-05-12 | $348.79K derived: sum of 3 quarters · filed 2026-05-12 | $471.43K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-12-31 | $11.48K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$199.80K derived: sum of 2 quarters · filed 2026-03-31 | -$77.16K derived: sum of 3 quarters · filed 2026-08-11 | $127.37K 10-K · filed 2026-03-31 | |
| 2025-09-30 | -$211.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$88.64K derived: sum of 2 quarters · filed 2026-08-11 | $115.89K 10-Q · filed 2025-11-13 | $228.97K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-06-30 | $122.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $327.17K 10-Q · filed 2026-08-11 | $440.25K derived: sum of 3 quarters · filed 2026-08-11 | $672.50K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-03-31 | $204.53K 10-Q · filed 2026-05-12 | $317.61K derived: sum of 2 quarters · filed 2026-05-12 | $549.86K derived: sum of 3 quarters · filed 2026-05-12 | $712.47K derived: sum of 4 quarters · filed 2026-05-12 | |
| 2024-12-31 | $113.08K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $345.33K derived: sum of 2 quarters · filed 2026-03-31 | $507.94K derived: sum of 3 quarters · filed 2026-03-31 | $477.26K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $232.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $394.86K derived: sum of 2 quarters · filed 2025-11-13 | $364.18K 10-Q · filed 2025-11-13 | $497.60K derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | $162.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $131.93K 10-Q · filed 2025-08-05 | $265.35K derived: sum of 3 quarters · filed 2025-08-05 | $361.92K derived: sum of 4 quarters · filed 2025-08-05 | |
| 2024-03-31 | -$30.68K 10-Q · filed 2025-05-12 | $102.75K derived: sum of 2 quarters · filed 2025-05-12 | $199.31K derived: sum of 3 quarters · filed 2025-05-12 | $389.63K derived: sum of 4 quarters · filed 2025-05-12 | |
| 2023-12-31 | $133.42K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $229.99K derived: sum of 2 quarters · filed 2025-02-27 | $420.31K derived: sum of 3 quarters · filed 2025-02-27 | $759.01K 10-K · filed 2025-02-27 | |
| 2023-09-30 | $96.56K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $286.88K derived: sum of 2 quarters · filed 2024-11-07 | $625.59K 10-Q · filed 2024-11-07 | $1.34M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $190.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $529.03K 10-Q · filed 2024-08-14 | $1.24M derived: sum of 3 quarters · filed 2024-08-14 | $1.72M derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $338.71K 10-Q · filed 2024-05-13 | $1.05M derived: sum of 2 quarters · filed 2024-05-13 | $1.53M derived: sum of 3 quarters · filed 2024-05-13 | $2.02M derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | $710.24K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $1.19M derived: sum of 2 quarters · filed 2024-03-28 | $1.68M derived: sum of 3 quarters · filed 2024-03-28 | $2.67M 10-K · filed 2024-03-28 | $2.67M 10-K · filed 2023-03-30 |
| 2022-09-30 | $476.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $968.19K derived: sum of 2 quarters · filed 2023-11-14 | $1.96M 10-Q · filed 2023-11-14 | $2.65M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $491.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.49M 10-Q · filed 2023-08-10 | $2.17M derived: sum of 3 quarters · filed 2023-08-10 | $2.87M derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $994.61K 10-Q · filed 2023-05-11 | $1.68M derived: sum of 2 quarters · filed 2023-05-11 | $2.38M derived: sum of 3 quarters · filed 2023-05-11 | $3.18M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $686.17K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $1.39M derived: sum of 2 quarters · filed 2023-03-30 | $2.18M derived: sum of 3 quarters · filed 2023-03-30 | $3.76M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $700.62K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.49M derived: sum of 2 quarters · filed 2022-11-14 | $3.07M 10-Q · filed 2022-11-14 | $3.48M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $793.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $2.37M 10-Q · filed 2022-08-15 | $2.78M derived: sum of 3 quarters · filed 2022-08-15 | $3.19M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $1.58M 10-Q · filed 2022-05-16 | $1.98M derived: sum of 2 quarters · filed 2022-05-16 | $2.40M derived: sum of 3 quarters · filed 2022-05-16 | $2.98M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $403.19K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $820.66K derived: sum of 2 quarters · filed 2022-03-31 | $1.40M derived: sum of 3 quarters · filed 2022-03-31 | $1.85M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $417.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $996.24K derived: sum of 2 quarters · filed 2021-11-15 | $1.45M 10-Q · filed 2021-11-15 | $1.97M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $578.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $1.03M 10-Q · filed 2021-08-12 | $1.55M derived: sum of 3 quarters · filed 2021-08-12 | $2.01M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $451.96K 10-Q · filed 2021-05-14 | $976.18K derived: sum of 2 quarters · filed 2021-05-14 | $1.43M derived: sum of 3 quarters · filed 2021-05-14 | $2.05M derived: sum of 4 quarters · filed 2021-05-14 | |
| 2019-12-31 | $524.22K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | $977.90K derived: sum of 2 quarters · filed 2021-03-19 | $1.60M derived: sum of 3 quarters · filed 2021-03-19 | $2.29M 10-K · filed 2021-03-19 | |
| 2019-09-30 | $453.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $1.07M derived: sum of 2 quarters · filed 2020-11-16 | $1.76M 10-Q · filed 2020-11-16 | $2.38M derived: sum of 4 quarters · filed 2020-11-16 | |
| 2019-06-30 | $617.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $1.31M 10-Q · filed 2020-08-14 | $1.93M derived: sum of 3 quarters · filed 2020-08-14 | $2.54M derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | $691.14K 10-Q · filed 2020-05-15 | $1.31M derived: sum of 2 quarters · filed 2020-05-15 | $1.92M derived: sum of 3 quarters · filed 2020-05-15 | $5.14M derived: sum of 4 quarters · filed 2020-05-15 | |
| 2018-12-31 | $618.59K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $1.23M derived: sum of 2 quarters · filed 2020-03-25 | $4.45M derived: sum of 3 quarters · filed 2020-03-25 | $4.60M 10-K · filed 2020-03-25 | |
| 2018-09-30 | $614.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $3.83M derived: sum of 2 quarters · filed 2019-11-14 | $3.99M 10-Q · filed 2019-11-14 | $4.14M derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | $3.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $3.37M 10-Q · filed 2019-08-14 | $3.53M derived: sum of 3 quarters · filed 2019-08-14 | $3.67M derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | $153.67K 10-Q · filed 2019-05-15 | $307.43K derived: sum of 2 quarters · filed 2019-05-15 | $454.32K derived: sum of 3 quarters · filed 2019-05-15 | $1.14M derived: sum of 4 quarters · filed 2019-05-15 | |
| 2017-12-31 | $153.76K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $300.65K derived: sum of 2 quarters · filed 2019-03-29 | $987.78K derived: sum of 3 quarters · filed 2019-03-29 | $1.11M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $146.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $834.02K derived: sum of 2 quarters · filed 2018-11-14 | $951.49K 10-Q · filed 2018-11-14 | $1.13M derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | $687.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $804.59K 10-Q · filed 2018-08-14 | $984.52K derived: sum of 3 quarters · filed 2018-08-14 | $1.42M derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | $117.47K 10-Q · filed 2018-05-11 | $297.39K derived: sum of 2 quarters · filed 2018-05-11 | $729.97K derived: sum of 3 quarters · filed 2018-05-11 | $1.01M derived: sum of 4 quarters · filed 2018-05-11 | |
| 2016-12-31 | $179.93K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-27 | $612.50K derived: sum of 2 quarters · filed 2018-03-27 | $896.01K derived: sum of 3 quarters · filed 2018-03-27 | $1.51M 10-K · filed 2018-03-27 | |
| 2016-09-30 | $432.57K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $716.08K derived: sum of 2 quarters · filed 2017-11-14 | $1.33M 10-Q · filed 2017-11-14 | $1.56M derived: sum of 4 quarters · filed 2017-11-14 | |
| 2016-06-30 | $283.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $898.52K 10-Q · filed 2017-08-14 | $1.13M derived: sum of 3 quarters · filed 2017-08-14 | $1.44M derived: sum of 4 quarters · filed 2017-08-14 | |
| 2016-03-31 | $615.01K 10-Q · filed 2017-05-12 | $847.96K derived: sum of 2 quarters · filed 2017-05-12 | $1.15M derived: sum of 3 quarters · filed 2017-05-12 | $1.62M derived: sum of 4 quarters · filed 2017-05-12 | |
| 2015-12-31 | $232.95K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | $539.73K derived: sum of 2 quarters · filed 2017-03-24 | $1.00M derived: sum of 3 quarters · filed 2017-03-24 | $1.85M 10-K · filed 2017-03-24 | |
| 2015-09-30 | $306.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $768.02K derived: sum of 2 quarters · filed 2016-11-10 | $1.62M 10-Q · filed 2016-11-10 | $1.95M derived: sum of 4 quarters · filed 2016-11-10 | |
| 2015-06-30 | $461.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $1.31M 10-Q · filed 2016-08-15 | $1.64M derived: sum of 3 quarters · filed 2016-08-15 | $2.17M derived: sum of 4 quarters · filed 2016-08-15 | |
| 2015-03-31 | $848.84K 10-Q · filed 2016-05-16 | $1.18M derived: sum of 2 quarters · filed 2016-05-16 | $1.71M derived: sum of 3 quarters · filed 2016-05-16 | $2.83M derived: sum of 4 quarters · filed 2016-05-16 | |
| 2014-12-31 | $331.50K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $863.66K derived: sum of 2 quarters · filed 2016-03-30 | $1.98M derived: sum of 3 quarters · filed 2016-03-30 | $2.59M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $532.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | $1.65M derived: sum of 2 quarters · filed 2015-11-05 | $2.25M 10-Q · filed 2015-11-05 | $2.49M derived: sum of 4 quarters · filed 2016-03-30 | |
| 2014-06-30 | $1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $1.72M 10-Q · filed 2015-08-10 | $1.96M derived: sum of 3 quarters · filed 2016-03-30 | $2.22M derived: sum of 4 quarters · filed 2016-03-30 | |
| 2014-03-31 | $607.23K 10-Q · filed 2015-05-11 | $846.72K derived: sum of 2 quarters · filed 2016-03-30 | $1.11M derived: sum of 3 quarters · filed 2016-03-30 | $1.58M derived: sum of 4 quarters · filed 2016-03-30 | |
| 2013-12-31 | $239.49K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $500.76K derived: sum of 2 quarters · filed 2016-03-30 | $972.25K derived: sum of 3 quarters · filed 2016-03-30 | $1.24M 10-K · filed 2016-03-30 | $1.22M 10-K · filed 2014-03-13 |
| 2013-09-30 | $261.28K 10-Q · filed 2013-11-12 | $732.76K derived: sum of 2 quarters · filed 2013-11-12 | $995.95K 10-Q · filed 2014-11-10 | $1.29M derived: sum of 4 quarters · filed 2015-03-12 | |
| 2013-06-30 | $471.48K 10-Q · filed 2013-08-08 | $734.67K 10-Q · filed 2013-08-08 | $1.03M derived: sum of 3 quarters · filed 2015-03-12 | $1.30M derived: sum of 4 quarters · filed 2015-03-12 | |
| 2013-03-31 | $263.19K 10-Q · filed 2013-05-09 | $555.97K derived: sum of 2 quarters · filed 2015-03-12 | $832.07K derived: sum of 3 quarters · filed 2015-03-12 | $1.10M derived: sum of 4 quarters · filed 2015-03-12 | |
| 2012-12-31 | $292.77K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $568.88K derived: sum of 2 quarters · filed 2015-03-12 | $838.64K derived: sum of 3 quarters · filed 2015-03-12 | $1.14M 10-K · filed 2015-03-12 | $1.08M 10-K · filed 2013-03-18 |
| 2012-09-30 | $276.11K 10-Q · filed 2013-11-12 | $545.86K derived: sum of 2 quarters · filed 2013-11-12 | $850.99K 10-Q · filed 2013-11-12 | $994.43K derived: sum of 4 quarters · filed 2014-03-13 | |
| 2012-06-30 | $269.76K 10-Q · filed 2013-08-08 | $557.02K 10-Q · filed 2013-08-08 | $718.33K derived: sum of 3 quarters · filed 2014-03-13 | $1.05M derived: sum of 4 quarters · filed 2014-03-13 | |
| 2012-03-31 | $305.13K 10-Q · filed 2013-05-09 | $448.57K derived: sum of 2 quarters · filed 2014-03-13 | $781.49K derived: sum of 3 quarters · filed 2014-03-13 | $1.01M derived: sum of 4 quarters · filed 2014-03-13 | |
| 2011-12-31 | $143.44K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $476.36K derived: sum of 2 quarters · filed 2014-03-13 | $709.46K derived: sum of 3 quarters · filed 2014-03-13 | $1.04M 10-K · filed 2014-03-13 | |
| 2011-09-30 | $332.92K 10-Q · filed 2012-11-09 | $566.02K derived: sum of 2 quarters · filed 2012-11-09 | $892.89K 10-Q · filed 2012-11-09 | $994.64K derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-06-30 | $233.10K 10-Q · filed 2012-08-14 | $559.98K 10-Q · filed 2012-08-14 | $661.72K derived: sum of 3 quarters · filed 2013-03-18 | $1.08M derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-03-31 | $326.88K 10-Q · filed 2012-05-15 | $428.62K derived: sum of 2 quarters · filed 2013-03-18 | $846.64K derived: sum of 3 quarters · filed 2013-03-18 | ||
| 2010-12-31 | $101.74K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $519.76K derived: sum of 2 quarters · filed 2013-03-18 | $1.30M 10-K · filed 2013-03-18 | ||
| 2010-09-30 | $418.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $1.19M 10-Q · filed 2011-11-10 | |||
| 2010-06-30 | $775.62K 10-Q · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |